GeneThera (CE) Quote - GTHR

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.0001

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.000001 52 Week Range 0.0001

Market Cap

3.533k

Previous Close

0.0001

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

35,333,319

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

-0.03

Revenue

Net Profit

-1.01M

GeneThera is a biotechnology company that specializes in developing diagnostic tests and vaccines for zoonotic diseases. These are diseases that originate in animals and are capable of causing infectious diseases in humans. More than 80% of all human infectious disease are caused by zoonotic viruses... GeneThera is a biotechnology company that specializes in developing diagnostic tests and vaccines for zoonotic diseases. These are diseases that originate in animals and are capable of causing infectious diseases in humans. More than 80% of all human infectious disease are caused by zoonotic viruses and bacteria. Examples of infectious agents transmitted from animals to humans are, SARS-Cov-2, E.Coli, Mad Cow disease, and Mycobacterium Avium Sub. Paratuberculosis. GeneThera's technology and business model are dedicated to developing the infrastructure of a global network that operates as a Zoonotic Infectious Disease Alert Shield (ZIDAS) to control and prevent pandemics from developing. Genethera's model is based on an Ultrahigh Throughput Molecular Robotic/AI Platform (MORAP) that combines the use of advanced robotic integrated systems with Artificial Intelligence (AI). This technology platform can process millions of samples, collecting, storing, and analyzing data. Genethera has designed a 2nd generation robotic prototype. The system is capable of processing over 100,000 samples/daily with minimum human intervention. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.genethera.net

Headquarters

Las Vegas, Nevada, USA

Founded

GeneThera Inc (CE) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker GTHR. The last closing price for GeneThera (CE) was US$0. Over the last year, GeneThera (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

GeneThera (CE) currently has 35,333,319 shares outstanding. The market capitalization of GeneThera (CE) is US$3,533.33 . GeneThera (CE) has a price to earnings ratio (PE ratio) of 0.00.

GeneThera, Inc. (GTHRE: OTCQB) | Symbol Change

Tue, Sep 10, 2013 12:00 - GeneThera, Inc. (GTHRE: OTCQB) - Symbol Change - The symbol, GTHRE, is no longer a valid symbol for GeneThera, Inc.. As of Tue, Sep 10, 2013, the new trading symbol is...

Applied Genetics Initiates Commercial Operation

Applied Genetics Initiates Commercial Operation PR Newswire WESTMINSTER, Colo., June 25, 2012 WESTMINSTER, Colo., June 25, 2012 /PRNewswire/ -- GeneThera Inc. (OTCQB: GTHR) is pleased to announce...

Applied Genetics Signs Agreement With The National University Of Mexico (UNAM)

Applied Genetics Signs Agreement With The National University Of Mexico (UNAM) PR Newswire WESTMINSTER, Colo., May 16, 2012 WESTMINSTER, Colo., May 16, 2012 /PRNewswire/ -- GeneThera, Inc...

Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada

Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada PR Newswire WESTMINSTER, Colo., Feb. 22, 2012 WESTMINSTER, Colo., Feb. 22, 2012 /PRNewswire/ -- GeneThera Inc...

GeneThera, Inc. Acquires Applied Genetics, S.A.

GeneThera, Inc. Acquires Applied Genetics, S.A. PR Newswire WESTMINSTER, Colo., Jan. 25, 2012 WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/ -- GeneThera, Inc. (OTCQB: GTHR) announced today...

Applied Genetics Appoints Dr. Milici Interim President

WESTMINSTER, CO -- (Marketwire) -- 01/10/12 -- GeneThera, Inc. (OTCQB: GTHR) (PINKSHEETS: GTHR) announced today that Applied Genetics has appointed Dr. Tony Milici as the new Interim President of...

GeneThera Finalizes License and Research Agreement With Two Leading Italian Universities; Agreement Represents Key Step in Effor

ARVADA, CO -- (Marketwire) -- 09/22/09 -- GeneThera, Inc. (PINKSHEETS: GTHR), an international biotechnology company, today announced it has finalized a license and research agreement with two...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0.0001	0.0001	0.0001	12363	0.0001	CS
52	9.9E-5	9900	1.0E-6	0.0001	1.0E-6	6681	9.259E-5	CS
156	-0.04148	-99.7594997595	0.04158	0.049	1.0E-6	17365	0.02223755	CS
260	-0.0073	-98.6486486486	0.0074	0.47	1.0E-6	80102	0.05697414	CS

GTHR - Frequently Asked Questions (FAQ)

What is the current GeneThera (CE) share price?

The current share price of GeneThera (CE) is US$ 0.0001

How many GeneThera (CE) shares are in issue?

GeneThera (CE) has 35,333,319 shares in issue

What is the market cap of GeneThera (CE)?

The market capitalisation of GeneThera (CE) is USD 3.53k

What is the 1 year trading range for GeneThera (CE) share price?

GeneThera (CE) has traded in the range of US$ 0.000001 to US$ 0.0001 during the past year

What is the reporting currency for GeneThera (CE)?

GeneThera (CE) reports financial results in USD

What is the latest annual profit for GeneThera (CE)?

The latest annual profit of GeneThera (CE) is USD -1.01M

What is the registered address of GeneThera (CE)?

The registered address for GeneThera (CE) is 5348 VEGAS DRIVE, LAS VEGAS, NEVADA, 89108

What is the GeneThera (CE) website address?

The website address for GeneThera (CE) is www.genethera.net

Which industry sector does GeneThera (CE) operate in?

GeneThera (CE) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EGIOQEdgio Inc (CE)	US$ 0.01 (999,900.00%)	584
AAGRAfrican Agriculture Holdings Inc (CE)	US$ 0.008 (799,900.00%)	477
THCBFTHC Biomed International Limited (CE)	US$ 0.001 (99,900.00%)	100
AEORFAEON REIT Investment Corporation (PK)	US$ 796.08 (26,436.00%)	1
EFTReFFECTOR Therapeutics Inc (CE)	US$ 0.0002 (19,900.00%)	225
UFABQUnique Fabricating Inc (CE)	US$ 0.000001 (-99.98%)	102.53k
VICFFVice Health and Wellness Inc (CE)	US$ 0.000001 (-99.97%)	996
SAFSSafer Shot Inc (CE)	US$ 0.000001 (-99.93%)	2.54M
ERFBERF Wireless Inc (CE)	US$ 0.0001 (-99.89%)	99.77k
ARVLFArrival (CE)	US$ 0.0002 (-99.60%)	42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0.0038 (52.00%)	608.97M
HMBLHUMBL Inc (PK)	US$ 0.0009 (0.00%)	546.25M
PHILPHI Group Inc (PK)	US$ 0.0003 (0.00%)	501.07M
CBIACanopus Biopharma Inc (PK)	US$ 0.0002 (100.00%)	281.95M
RDARRaadr Inc (PK)	US$ 0.00125 (-10.71%)	169.44M